{"id":"https://openalex.org/W3134530867","doi":"https://doi.org/10.3389/fonc.2021.636561","title":"Value of Adaptive Trials and Surrogate Endpoints for Clinical Decision-Making in Rare Cancers","display_name":"Value of Adaptive Trials and Surrogate Endpoints for Clinical Decision-Making in Rare Cancers","alternate_titles":[],"publication_year":2021,"publication_date":"2021-03-08","ids":{"openalex":"https://openalex.org/W3134530867","doi":"https://doi.org/10.3389/fonc.2021.636561","mag":"3134530867","pmid":"https://pubmed.ncbi.nlm.nih.gov/33763370","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7982798"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2021.636561","doi":"https://doi.org/10.3389/fonc.2021.636561","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2021.636561","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2021.636561/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3134530867"],"child_works_count":2,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fonc.2021.636561/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008879062","display_name":"Andriy Krendyukov","orcid":"https://orcid.org/0000-0001-8557-1520","observed_orcids":["https://orcid.org/0000-0001-8557-1520"]},"institutions":[{"id":"https://openalex.org/I4210086077","display_name":"Apogenix (Germany)","ror":"https://ror.org/00g9je304","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210086077"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Andriy Krendyukov","raw_affiliation_strings":["Apogenix AG, Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Apogenix AG, Heidelberg, Germany","institution_ids":["https://openalex.org/I4210086077"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112122134","display_name":"Sanjay Singhvi","orcid":"https://orcid.org/0009-0005-2205-5453","observed_orcids":["https://orcid.org/0009-0005-2205-5453"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sanjay Singhvi","raw_affiliation_strings":["System Analytic, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"System Analytic, London, United Kingdom","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045399838","display_name":"Markus Zabransky","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Markus Zabransky","raw_affiliation_strings":["Sandoz GmbH, Holzkirchen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sandoz GmbH, Holzkirchen, Germany","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5008879062"],"corresponding_institution_ids":["https://openalex.org/I4210086077"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":0.1055,"has_fulltext":true,"cited_by_count":13,"citation_normalized_percentile":{"value":0.14511041,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"11","issue":null,"first_page":"636561","last_page":"636561"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11296","display_name":"COVID-19 and healthcare impacts","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adaptive-trial-design","display_name":"adaptive trial design","score":0.781000018119812},{"id":"https://openalex.org/keywords/rare-tumor","display_name":"rare tumor","score":0.9300000071525574},{"id":"https://openalex.org/keywords/surrogate-endpoints","display_name":"surrogate endpoints","score":0.9900000095367432},{"id":"https://openalex.org/keywords/clinical-decision-making","display_name":"clinical decision-making","score":0.8600000143051147},{"id":"https://openalex.org/keywords/oncologist-perspectives","display_name":"oncologists' perspectives","score":0.7680000066757202},{"id":"https://openalex.org/keywords/futility-analysis","display_name":"futility analysis","score":0.7490000128746033},{"id":"https://openalex.org/keywords/interim-analysis","display_name":"interim analysis","score":0.996999979019165},{"id":"https://openalex.org/keywords/adaptive-randomization","display_name":"adaptive randomization","score":0.9710000157356262},{"id":"https://openalex.org/keywords/adaptive-sample-size","display_name":"adaptive sample size","score":0.9710000157356262},{"id":"https://openalex.org/keywords/value-of-evidence","display_name":"value of evidence","score":0.5139999985694885},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.40700000524520874},{"id":"https://openalex.org/keywords/trial-design","display_name":"trial design","score":0.3230000138282776}],"concepts":[{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.7040627598762512},{"id":"https://openalex.org/C2776957806","wikidata":"https://www.wikidata.org/wiki/Q4895105","display_name":"Interim","level":2,"score":0.6619527339935303},{"id":"https://openalex.org/C141341695","wikidata":"https://www.wikidata.org/wiki/Q2368661","display_name":"Surrogate endpoint","level":2,"score":0.6615003943443298},{"id":"https://openalex.org/C129848803","wikidata":"https://www.wikidata.org/wiki/Q2564360","display_name":"Sample size determination","level":2,"score":0.6471425294876099},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6442803740501404},{"id":"https://openalex.org/C61943457","wikidata":"https://www.wikidata.org/wiki/Q6046661","display_name":"Interim analysis","level":3,"score":0.6187226176261902},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5548428893089294},{"id":"https://openalex.org/C204243189","wikidata":"https://www.wikidata.org/wiki/Q1363085","display_name":"Randomization","level":3,"score":0.5418674349784851},{"id":"https://openalex.org/C2982777018","wikidata":"https://www.wikidata.org/wiki/Q99268086","display_name":"Adaptive design","level":3,"score":0.44338223338127136},{"id":"https://openalex.org/C148482608","wikidata":"https://www.wikidata.org/wiki/Q17007018","display_name":"Clinical study design","level":3,"score":0.43333736062049866},{"id":"https://openalex.org/C2779318504","wikidata":"https://www.wikidata.org/wiki/Q1438035","display_name":"Research design","level":2,"score":0.4281248450279236},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4228171706199646},{"id":"https://openalex.org/C19527891","wikidata":"https://www.wikidata.org/wiki/Q1120908","display_name":"Medical physics","level":1,"score":0.39686572551727295},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20528903603553772},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.14628878235816956},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C166957645","wikidata":"https://www.wikidata.org/wiki/Q23498","display_name":"Archaeology","level":1,"score":0.0},{"id":"https://openalex.org/C95457728","wikidata":"https://www.wikidata.org/wiki/Q309","display_name":"History","level":0,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fonc.2021.636561","doi":"https://doi.org/10.3389/fonc.2021.636561","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2021.636561","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2021.636561/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmid:33763370","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33763370","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7982798","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7982798/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:25d25a4bd1254b358052f7bca6da708d","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/25d25a4bd1254b358052f7bca6da708d","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 11 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2021.636561","doi":"https://doi.org/10.3389/fonc.2021.636561","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2021.636561","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2021.636561/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3134530867.pdf","grobid_xml":"https://content.openalex.org/works/W3134530867.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W2006446454","https://openalex.org/W2011983555","https://openalex.org/W2027266396","https://openalex.org/W2044439361","https://openalex.org/W2064117019","https://openalex.org/W2065646678","https://openalex.org/W2117173606","https://openalex.org/W2126438085","https://openalex.org/W2136919572","https://openalex.org/W2145396043","https://openalex.org/W2151333691","https://openalex.org/W2166602936","https://openalex.org/W2301701445","https://openalex.org/W2616456558","https://openalex.org/W2729284305","https://openalex.org/W2738426809","https://openalex.org/W2753603515","https://openalex.org/W2754725540","https://openalex.org/W2755672614","https://openalex.org/W2769583258","https://openalex.org/W2793703203","https://openalex.org/W2860986227","https://openalex.org/W2889985053","https://openalex.org/W2981350376","https://openalex.org/W2983623050","https://openalex.org/W3007299494","https://openalex.org/W3009999522","https://openalex.org/W3015759203","https://openalex.org/W3033822289","https://openalex.org/W3035123324","https://openalex.org/W3048473311","https://openalex.org/W3089203425"],"related_works":["https://openalex.org/W3089203425","https://openalex.org/W4213160522","https://openalex.org/W2138143000","https://openalex.org/W2100722016","https://openalex.org/W3087772406","https://openalex.org/W4399360789","https://openalex.org/W2148825300","https://openalex.org/W7221554479","https://openalex.org/W6927662125","https://openalex.org/W2266707907"],"abstract_inverted_index":{"Despite":[0],"high-level":[1],"endorsement,":[2],"the":[3,70,93,125,216],"number":[4],"of":[5,20,46,60,72,77,83,92,121,143,205],"adaptive":[6,49,78,105,146,153,157,167],"Phase":[7,100],"II/III":[8,101],"trials":[9,102,169],"in":[10,26,36,52,116,193,195],"rare":[11,37,53,117,161],"cancers":[12],"needs":[13],"to":[14,33,124,138,199,209,215],"be":[15],"improved,":[16],"with":[17,103,170],"better":[18],"understanding":[19],"their":[21],"value":[22,115,174],"for":[23,48,86,177],"clinical":[24,87,132,168,178,196],"decisions":[25],"daily":[27],"practice.":[28],"This":[29],"paper":[30],"describes":[31],"approaches":[32],"trial":[34,50,79,128,197],"design":[35,106],"cancers,":[38],"which":[39],"has":[40],"been":[41],"supplemented":[42],"by":[43,119,141],"a":[44,173,190],"search":[45],"ClinicalTrials.gov":[47],"designs":[51,147,198],"cancer.":[54],"In":[55,159],"addition,":[56],"an":[57,104],"online":[58,94],"survey":[59,95],"3,200":[61],"oncologists":[62,163],"was":[63,112],"conducted.":[64],"Practicing":[65],"physicians":[66],"were":[67,134,148],"questioned":[68],"on":[69],"importance":[71,176],"different":[73],"evidence":[74,98,165],"levels,":[75],"types":[76],"design,":[80],"and":[81,107,156,175,202],"categories":[82],"surrogate":[84],"endpoints":[85,133],"decision":[88,179],"making.":[89],"The":[90],"results":[91],"revealed":[96],"that":[97],"from":[99,166],"relatively":[108],"small":[109],"sample":[110,154],"size":[111],"considered":[113,135],"high":[114,172],"cancer":[118,162],"97%":[120],"responders,":[122],"similar":[123],"randomized":[126,184],"controlled":[127,185],"rating":[129],"(82%).":[130],"Surrogate":[131],"valuable":[136],"alternatives":[137],"overall":[139],"survival":[140],"80%":[142],"oncologists.":[144],"Preferred":[145],"futility":[149],"analysis,":[150,152],"interim":[151],"size,":[155],"randomization.":[158],"conclusion,":[160],"rate":[164],"as":[171,182],"making":[180],"processes":[181],"conventional":[183],"trials.":[186],"All":[187],"stakeholders":[188],"have":[189],"vested":[191],"interest":[192],"advances":[194],"ensure":[200],"efficient":[201],"timely":[203],"development":[204],"innovative":[206],"medicinal":[207],"products":[208],"allow":[210],"more":[211],"patients":[212],"faster":[213],"access":[214],"pivotal":[217],"treatment.":[218]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3134530867","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2021-03-15T00:00:00"}
